target glp 1 Most important traditional organ targets for GLP-1 and its actions on For best results Understanding GLP-1 vs. GIP Medications:

No great, actually

Melanie Jay, Director of NYU Langone Comprehensive Program on Obesity Research, captured this dynamic perfectly: "It creates a lot of demand, and it creates openings for people to exploit that demand." Regulatory lag The FDA enforcement process is slow relative to the speed at which new scam products appear

In-vitro studies do not show efficacy of a product in actual human beings, and just because a cell study showed more GLP-1 production doesnt mean that this will happen in a person and have the desired results in terms of weight

In contrast, Wegovy is dosed at higher levels specifically optimized for weight loss

But these drugs come at a cost